financetom
Business
financetom
/
Business
/
Lenz Therapeutics' eye disease drugs meet main goal of late-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lenz Therapeutics' eye disease drugs meet main goal of late-stage study
Apr 3, 2024 4:28 AM

April 3 (Reuters) - Lenz Therapeutics ( LENZ ) said on

Wednesday its experimental drugs to treat loss of near vision

met the main goal of a late-stage study.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved